Telephone:
+33 380 293 507 + +33 380 0293 031, ext. 13393
Professional
• 2000: Senior Master Lecturer-Practitioner, University of Burgundy, Department of Biography
• 1989: Master Lecturer-Practitioner, University of Burgundy, Department of
• 1980: Lecturer-Practitioner, University of Burgundy, Department of Physiology
• 1975: Temporary Lecturer, University of Burgundy, Department of Physiology
• 1972: Temporary Lecturer, University of Strasbourg, Department of Biochemistry Education
• 1992: State Research Director Doctorate
• 1977: PhD, University of Strasbourg,
• 1973: Master degree in research, University of Strasbourg
• 1972: Degree in Biochemistry, University of Strasbourg
• 1969-1971: Degree in Physiology, University of Burgundy Expertises
• Cellular physiology and pharmacology
• experimental models in physiology, pharmacology and pathology
• biomedical electronics and clinical functional tests
Professional Research: memberships
• International Society for Heart Research (ISHR), European Section
• French Group of Cardiovascular Research (GRRC)
• French Society of Pharmacology and Therapeutics
Medical:
• French Club of Digestive Motility (CFMD)
• French Group of Paediatric Hepatology, Gastroenterology and Nutrition
Reviewer
• Cellular and Molecular Life Sciences
• Fundamental and Clinical Pharmacology
• Journal of Cardiovascular Pharmacology
CV of Pierre ATHIAS – Page 1 of 3 – ed. 6/29/2007
Teatching Medical University Diploma:
Medical BA:
Medical Masters:
• Physiology and Pharmacology of ion channels
• Fundamentals in Biomedical Technology
• Cellular Models in Experimental Research
Research Students
• Master Student: 16 as supervisor, 1 as co-supervisor
• PhD Students: 13 as supervisor, 3 as co-supervisor
Grants & National funding:
• French Ministry of Education, annual since 1991
• French Institute of Health and Medical Research (INSERM): 1993-1996
Regional funding:
• Regional Council of Burgundy, annual since 1987
Foundations:
• French Foundation for Medical Research: 1988, 1992
• French Federation of Cardiology : 2002, 2003, 2005
• Burgundy Heart Association: 2002, 2004
Publications
2002.- Tissier C, Bes S, Vandroux D, Fantini E, Rochette L, Athias P. Specific
(last 5 years)
electromechanical responses of cardiomyocytes to individual and combined components of ischemia. Can. J. Physiol. Pharmacol, 80: 1145-1157
2003.- Schaeffer, C., D. Vandroux, L. Thomassin, P. Athias, L. Rochette and J. L.
Connat. Calcitonin gene-related peptide partly protects cultured smooth muscle cells from apoptosis induced by an oxidative stress via activation of ERK1/2 MAPK. Biochim Biophys Acta 1643(1-3): 65-73.
2004.- Chantome, A., A. Pance, N. Gauthier, D. Vandroux, J. Chenu, E. Solary, J. F.
Jeannin and S. Reveneau. Casein kinase II-mediated phosphorylation of NF-kB p65 subunit enhances inducible nitric oxide synthase gene transcription in vivo. J Biol Chem. 279(23): 23953-60.
2004.- Gambert, S., S. Bes-Houtmann, D. Vandroux, C. Tissier, C. Vergely-Vandriesse,
L. Rochette and P. Athias. Deep hypothermia during ischemia improves functional recovery and reduces free-radical generation in isolated reperfused rat heart. J Heart Lung Transplant 23(4): 487-91.
2004.- Vandroux, D., C. Schaeffer, C. Tissier, A. Lalande, S. Bes, L. Rochette and P.
Athias. "Microtubule alteration is an early cellular reaction to the metabolic challenge in ischemic cardiomyocytes." Mol Cell Biochem 258(1-2): 99-108.
2004.- Bès, S., Tatou, E., Vandroux, D., Tissier, C., Rochette, L., Athias, P. Physiological
and metabolic actions of mycophenolate mofetil on cultured newborn rat
CV of Pierre ATHIAS – Page 2 of 3 – ed. 6/29/2007
cardiomyocytes in normoxia and in simulated ischemia. Fund Appl Pharm 18: 287-298.
2005.- Bès, S., Vandroux, D., Tissier, C., Tatou, Rochette, L., Athias, P. Direct protection
by cyclosporin A of rat cardiomyocytes from simulated ischemia dysfunctions. Eur. J. Pharmacol. 511: 109-120
2005.- Tissier, C., D. Vandroux, L. Devillard, A. Brochot, D. Moreau, L. Rochette and P.
Athias. Substrate dependence of the postischemic cardiomyocyte recovery: dissociation between functional, metabolic and injury markers. Mol Cell Biochem 273(1-2): 43-55.
2005.- Jacquir S., Binczak S., Laurent G., Athias P., Bilbault J.M. Influence of
geometrical constraints on propagation in cardiac tissue. Computers in Cardiology, 2005 : 647- 650.
2006.- Durot, I., L. Devillard, C. Tissier, D. Vandroux, S. Voisin, S. Jaquir, L. Rochette
and P. Athias "Dependence on the phospholipid polyunsaturated fatty acids of the oxidative injury of isolated cardiomyocytes." Free Radic Res 40(3): 251-61.
2006.- Devillard, L., Vandroux, D., Tissier, C., Brochot, A., Voisin, S., Rochette, Athias, P.
Tubulin ligands suggest a microtubule-NADPH oxidase relationship in postischemic cardiomyocytes. Eur. J. Pharmacol. 548 : 64-73.
2006.- Bopassa J. C., Vandroux D., Ovize M., Ferrera R. Controlled reperfusion after
hypothermic heart preservation inhibits mitochondrial permeability transition-pore opening and enhances functional recovery. Am. J. Physiol. Heart. Circ. Physiol. 291(5): H2265-71.
• 1996 - Laboratory for Myocardial Research, Institute of Biochemistry, The
lectures
Hebrew University, Hadassah Medical School, Jerusalem, Israel
• 2000 - VERTEX Phamaceuticals Inc., Oxford, UK
• 2004 - Servier-IDRS, Neuilly, France
• 2007 – 9th National Meeting of the Electronicians of the National Center of
Scientifc Research (CNRS), Dijon, France
Community
• Treasurer of the Health & Nutrition Branch of the Regional VITAGORA
involvement
• Head of the Office of Innovation, Valorization and Technology Transfer of the
Burgundy FEDERATION INSTITUTE OF HEALTH LABORATORIES
• Consultant of the Health Dept of the BURGUNDY DEVELOPMENT AGENCY
• Vice president of the regional CLUB OF TECHNOLOGICAL CONTRACTORS
Personal
• Horse dressage, show jumping and eventing
interests
CV of Pierre ATHIAS – Page 3 of 3 – ed. 6/29/2007
Tobacco Treatment Medication Dosing Chart Nicotine Patch Nicotine Gum Nicotine Lozenge Nicotine Nasal Spray Nicotine Inhaler Bupropion SR Varenicline Name/Generic Available Strength Time to peak Plasma level Possible Reactions * Additional * Additional warnings: warnings: see back Instructions Cost (Average) For Maximum
Association des Disciplines Orthodontiques et Maxillo-Faciales Le chirurgien maxillo-facial peut réaliser les extractions dentaires difficiles. - cas de dent dévitalisée et ankylosée. - cas d'extractions dents multiples. - présence de kyste plus ou moins volumineux attenant aux dents. - risques de complications hémorragiques du fait de traitement anti-agrégant (Aspégic®, Kardégic®, P